Global Legal Chronicle: Jenscare Scientific’s Hong Kong IPO
October 19, 2022
O’Melveny represented Jenscare Scientific Co., Ltd. in its initial public offering and listing of shares on the Main Board of the Hong Kong Stock Exchange. This marks O’Melveny’s 12th Chapter 18A Hong Kong IPO completed for biotech companies, further solidifying the firm’s leading position in this field. The O’Melveny team for this transaction was led by corporate partners Ke Zhu, Ke Geng, and Ye Sun, with assistance from counsel Wendy Kan and Yazhe Liu, associates Sean Sy, Amy Sung, Rita Deng, Stella Yang, and Fan Wu, legal consultants Zixie Zhu and Yirong Du, senior legal assistant Cherry Ma, and trainee solicitor Ann Marie Choy. Partners Robert Plesnarski, Luc Moritz, counsel Billy Abbott and Dawn Lim provided tax and US legal opinion related advice.
Read the full article here.